SOUTH SAN FRANCISCO, Calif., April 30, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused...
Reports first quarter 2021 revenue of $9.2 million, GAAP diluted EPS of $0.11 and non-GAAP diluted EPS of $0.13Reports combined...
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled...
IP portfolio now totals over 160 patents issued, allowed, and pendingSALT LAKE CITY, April 30, 2021 (GLOBE NEWSWIRE) -- Clene...
NEW YORK and MAINZ, GERMANY, April 30, 2021 (GLOBE NEWSWIRE) — Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX)...
- NDAs filed in the U.S. and China in Mar. 2021 based on superior data from Phase 3 PROTECTIVE-2 trial...
82 Patient Pivotal cohort expected to commence in second half of 2021 BEDMINSTER, N.J. and SINGAPORE, April 30, 2021 (GLOBE...
Dividend amount: NOK 0.5 Declared currency: NOK Last day including right: 20 May 2021 Ex-date: 21 May 2021 Record date:...
MORRISVILLE, N.C., April 30, 2021 (GLOBE NEWSWIRE) -- The Illingworth Research Group, a Syneos Health® company, has been recognized with...
Oslo, Norway, 30 April 2021 - PCI Biotech’s (OSE: PCIB) first quarter 2021 interim report will be released on 7...
New JSC Olainfarm strategy is approvedThe Company reviewed operations in the main marketsJSC Olainfarm continued investments to modernize its operations...
Policy that would force physicians out of Covid fight not in public interestPOWELL RIVER, British Columbia, April 30, 2021 (GLOBE...
PARIS and CAMBRIDGE, Mass., April 30, 2021 (GLOBE NEWSWIRE) -- Biophytis SA (Euronext Growth Paris: ALBPS), a clinical-stage biotechnology company...
PRESS RELEASE April 30, 2021 During April, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has...
Press release Synairgen plc(‘Synairgen’ or the ‘Company’) Synairgen announces data from Home Cohort of SG016 Phase II trial of inhaled...
Glycotope Announces Poster Presentations at the 2021 American Society of Clinical Oncology (ASCO) Virtual Annual Meeting Berlin, Germany, April 30,...
Press ReleaseNicox Updates on Fera Pharmaceuticals’ Continuing Evaluation of NaproxcinodApril 30, 2021 – release at 7:30 am CET Sophia Antipolis,...
Leuven, BE, Boston, MA, US – April 30st, 2021 – 7.30 AM CET – Oxurion NV (Euronext Brussels: OXUR) is...
miDiagnostics accelerates with launch of rapid COVID-19 PCR test product Additional funding of 58 million euro for transition to a...
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (NASDAQ: HOWL), an innovative biopharmaceutical company pioneering the development...